Literature DB >> 2887109

Haplotypes identified by DNA restriction-fragment-length polymorphisms in the A-1 C-III A-IV gene region and hypertriglyceridemia.

J Stocks, H Paul, D Galton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2887109      PMCID: PMC1684224     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  23 in total

1.  DNA polymorphism adjacent to human apoprotein A-1 gene: relation to hypertriglyceridaemia.

Authors:  A Rees; C C Shoulders; J Stocks; D J Galton; F E Baralle
Journal:  Lancet       Date:  1983-02-26       Impact factor: 79.321

2.  DNA polymorphic patterns and haplotype arrangements of the apo A-1, apo C-III, apo A-IV gene cluster in different ethnic groups.

Authors:  H Paul; D Galton; J Stocks
Journal:  Hum Genet       Date:  1987-03       Impact factor: 4.132

3.  Nonrandom association of polymorphic restriction sites in the beta-globin gene cluster.

Authors:  S E Antonarakis; C D Boehm; P J Giardina; H H Kazazian
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

Review 4.  Regulation of plasma cholesterol by lipoprotein receptors.

Authors:  M S Brown; P T Kovanen; J L Goldstein
Journal:  Science       Date:  1981-05-08       Impact factor: 47.728

5.  Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance.

Authors:  C R Sharpe; A Sidoli; C S Shelley; M A Lucero; C C Shoulders; F E Baralle
Journal:  Nucleic Acids Res       Date:  1984-05-11       Impact factor: 16.971

6.  Isolation and sequence analysis of the human apolipoprotein CIII gene and the intergenic region between the apo AI and apo CIII genes.

Authors:  A A Protter; B Levy-Wilson; J Miller; G Bencen; T White; J J Seilhamer
Journal:  DNA       Date:  1984-12

7.  Polymorphism of DNA sequence in the beta-globin gene region. Application to prenatal diagnosis of beta 0 thalassemia in Sardinia.

Authors:  Y W Kan; K Y Lee; M Furbetta; A Angius; A Cao
Journal:  N Engl J Med       Date:  1980-01-24       Impact factor: 91.245

8.  Linkage of human apolipoproteins A-I and C-III genes.

Authors:  S K Karathanasis; J McPherson; V I Zannis; J L Breslow
Journal:  Nature       Date:  1983 Jul 28-Aug 3       Impact factor: 49.962

9.  A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins.

Authors:  K H Weisgraber; T P Bersot; R W Mahley; G Franceschini; C R Sirtori
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

10.  Isolation and DNA sequence of full-length cDNA and of the entire gene for human apolipoprotein AI--discovery of a new genetic polymorphism in the apo AI gene.

Authors:  J J Seilhamer; A A Protter; P Frossard; B Levy-Wilson
Journal:  DNA       Date:  1984-08
View more
  7 in total

1.  The apolipoprotein CIII T2854G variants are associated with postprandial triacylglycerol concentrations in normolipidemic Korean men.

Authors:  Sang-Koo Woo; Hyun-Sik Kang
Journal:  J Hum Genet       Date:  2003-09-27       Impact factor: 3.172

Review 2.  DNA polymorphism and the study of disease associations.

Authors:  D N Cooper; J F Clayton
Journal:  Hum Genet       Date:  1988-04       Impact factor: 4.132

3.  An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms.

Authors:  M Dammerman; L A Sandkuijl; J L Halaas; W Chung; J L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

4.  Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11.

Authors:  Michael Olivier; Xujing Wang; Regina Cole; Brian Gau; Jessica Kim; Edward M Rubin; Len A Pennacchio
Journal:  Genomics       Date:  2004-05       Impact factor: 5.736

5.  An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population.

Authors:  Q Zeng; M Dammerman; Y Takada; A Matsunaga; J L Breslow; J Sasaki
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

6.  Apolipoprotein C3 SstI polymorphism in the risk assessment of CAD.

Authors:  S Chhabra; R Narang; R Lakshmy; S Vasisht; D P Agarwal; L M Srivastava; S C Manchanda; N Das
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

7.  Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian Indians.

Authors:  S Chhabra; R Narang; L R Krishnan; S Vasisht; D P Agarwal; L M Srivastava; S C Manchanda; N Das
Journal:  BMC Genet       Date:  2002-06-06       Impact factor: 2.797

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.